Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
0.00%
)
US TECH 100
26,630.40
(
0.63%
)
Dow Jones
48,861.81
(
0.00%
)
Brent Oil
109.45
(
-2.61%
)
Bitcoin
76,362.49
(
0.77%
)
News Focus
News Focus

Replies to post #503502 on Anavex Life Sciences Corp (AVXL)

Replies to #503502 on Anavex Life Sciences Corp (AVXL)
icon url

boi568

10/17/25 7:01 PM

#503504 RE: Investor2014 #503502

Sure, they will condition a safe and efficacious AD drug for years because of a missed co-primary that wasn't required by them and, even if it were, is overcome by a multiplicity fix.